Orzit S 250mg/125mg Injection
Marketer
Age Biotech
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Orzit S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curtailing infection spread. Administration must be solely under a physician's guidance. Adherence to the prescribed dosage schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms promptly to your doctor. Seek immediate medical attention for allergic reactions (e.g., skin rashes, itching, edema, respiratory distress). Disclose all current medications to your physician prior to commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Ample rest, nutritious food, and hydration are vital for optimal recovery. Your physician may order lab tests and imaging to monitor treatment response.
Uses of Orzit S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Orzit S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Orzit S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Orzit S 250mg/125mg Injection:
The medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Orzit S 250mg/125mg Injection works:
The injectable formulation Orzit S (250mg/125mg) unites the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Orzit S 250mg/125mg Injection may be taken with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Orzit S 250mg/125mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; however, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administering Orzit S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The injection Orzit S 250mg/125mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Orzit S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The 250mg/125mg Orzit S Injection requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for the 250mg/125mg Orzit S Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Orzit S 250mg/125mg Injection :
Omit a scheduled Orzit S 250mg/125mg Injection? Seek medical advice immediately.
Facts to Know About Orzit S 250mg/125mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Treatment Category | Drugs Against Infection |
3,018 People bought this recently